Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, July 28, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2015 second quarter and six-month financial results after the market closes on Tuesday, August 11, 2015. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, August 11, 2015, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-855-539-0900 (U.S.) or 1-412-455-6044 (International). To listen to the live call via Invuity's website, go to www.invuity.com, in the Even...Read More
SAN FRANCISCO, July 21, 2015 /PRNewswire/ -- Invuity, Inc. (Nasdaq: IVTY), a leading surgical photonics company, today reported that The Joint Commission has recognized its proprietary photonics technology as an important innovation in the prevention of unintended retained foreign objects (URFOs) that are left inside patients during surgery. The Joint Commission is the leading hospital accreditation and certification organization in the United States. It recently and independently assessed advanced methods for hospitals to prevent URFOs. In the July 2015 issue of TheSource™: Joint Commission Compliance Strategies, the Commission advised, "Another newer technology to consider is proprieta...Read More
SAN FRANCISCO, June 18, 2015 /PRNewswire/ -- Invuity, Inc. (Nasdaq: IVTY), a commercial-stage medical technology company pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures, today announced the closing of its initial public offering of 4,600,000 shares of its common stock (including 600,000 shares purchased by the underwriters pursuant to an option to purchase additional shares) at the public offering price of $12.00 per share, resulting in estimated net proceeds of approximately $47.8 million, after deducting underwriting discounts and commissions and estimated o...Read More
“Invuity’s Intelligent Photonics Technology is a must-have for all my surgical procedures, particularly lumpectomies, and skin and nipple sparing mastectomies. This technology enables me to make a single inframammary incision and clearly visualize deep into the surgical cavity all the way to the axilla. Additionally, it has enabled me to operate proficiently, improving the viability of the breast flap. I have reduced my surgical times while improving patient safety and aesthetic outcomes.”
Director, Comprehensive Breast Care Surgeons
Medical Director, Breast Health Program
Holy Redeemer Health System
“The Saber Waveguide with Yankauer is one of the most significant technological advancements in orthopedic surgery this year. I’m excited to begin using it in my total hip replacement, oncology and orthopedic trauma surgeries.”
UAB Medical Center
“The illumination of the operative field creating improved operative efficiency (with no longer needing to wear my headlight) along with added patient safety have made the Eikon Illuminated Retractor System the tool of choice in my skin sparing and nipple sparing mastectomies.”